NeueHealth PE Ratio 2019-2024 | NEUE
Current and historical p/e ratio for NeueHealth (NEUE) from 2019 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NeueHealth PE ratio as of May 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
NeueHealth PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-05-14 | 6.84 | 0.00 | |
2024-12-31 | 7.42 | $-22.63 | 0.00 |
2024-09-30 | 5.22 | $-51.16 | 0.00 |
2024-06-30 | 5.44 | $-123.68 | 0.00 |
2024-03-31 | 6.50 | $-130.73 | 0.00 |
2023-12-31 | 7.63 | $-151.20 | 0.00 |
2023-09-30 | 5.97 | $-208.73 | 0.00 |
2023-06-30 | 12.22 | $-167.70 | 0.00 |
2023-03-31 | 17.60 | $-188.00 | 0.00 |
2022-12-31 | 52.00 | $-189.60 | 0.00 |
2022-09-30 | 84.00 | $-204.80 | 0.00 |
2022-06-30 | 145.60 | $-203.20 | 0.00 |
2022-03-31 | 154.40 | $-189.60 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.061B | $0.937B |
NeueHealth is a healthcare company which provides health insurance policies principally in the United States. Its operating segments include Bright HealthCare and Consumer Care. NeueHealth, formerly known as Bright Health Group Inc., is based in MINNEAPOLIS. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $134.417B | 25.21 |
Elevance Health (ELV) | United States | $84.565B | 10.91 |
CVS Health (CVS) | United States | $75.952B | 9.44 |
Cencora (COR) | United States | $54.132B | 18.82 |
DiDi Global (DIDIY) | China | $21.231B | 32.22 |
Natera (NTRA) | United States | $20.665B | 0.00 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
Solventum (SOLV) | United States | $12.308B | 13.03 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
Doximity (DOCS) | United States | $11.108B | 57.77 |
CochLear (CHEOY) | Australia | $11.097B | 0.00 |
Revvity (RVTY) | United States | $10.729B | 18.46 |
ICON (ICLR) | Ireland | $10.678B | 9.93 |
Viatris (VTRS) | United States | $9.882B | 3.40 |
Avantor (AVTR) | United States | $8.756B | 12.72 |
HealthEquity (HQY) | United States | $8.482B | 41.73 |
Medpace Holdings (MEDP) | United States | $8.385B | 22.27 |
Sonic Healthcare (SKHHY) | Australia | $8.090B | 0.00 |
Charles River Laboratories (CRL) | United States | $6.825B | 13.37 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
BrightSpring Health Services (BTSG) | United States | $4.093B | 37.89 |
Bausch + Lomb (BLCO) | Canada | $4.082B | 24.06 |
Sotera Health (SHC) | United States | $3.636B | 20.66 |
Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
Surgery Partners (SGRY) | United States | $2.918B | 37.95 |
Concentras Parent (CON) | United States | $2.739B | 15.83 |
Organon (OGN) | United States | $2.090B | 2.22 |
Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
Premier (PINC) | United States | $2.056B | 14.07 |
Progyny (PGNY) | United States | $1.874B | 41.24 |
GeneDx Holdings (WGS) | United States | $1.696B | 65.33 |
PACS (PACS) | United States | $1.666B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.638B | 30.50 |
Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
Pediatrix Medical (MD) | United States | $1.219B | 9.27 |
Agilon Health (AGL) | United States | $1.105B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.054B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.892B | 13.93 |
Nutex Health (NUTX) | United States | $0.884B | 13.36 |
AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
Embecta (EMBC) | United States | $0.677B | 4.56 |
InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
Enhabit (EHAB) | United States | $0.536B | 44.08 |
Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
Sonida Senior Living (SNDA) | United States | $0.496B | 0.00 |
LifeMD (LFMD) | United States | $0.434B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.358B | 0.00 |
SBC Medicals (SBC) | United States | $0.348B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.203B | 0.00 |
Beauty Health (SKIN) | United States | $0.185B | 0.00 |
Oncology Institute (TOI) | United States | $0.179B | 0.00 |
DocGo (DCGO) | United States | $0.143B | 23.33 |
So-Young (SY) | China | $0.086B | 0.00 |
Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
OncoCyte (OCX) | United States | $0.074B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
KindlyMD (KDLY) | United States | $0.046B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
Biodesix (BDSX) | United States | $0.032B | 0.00 |
ModivCare (MODV) | United States | $0.014B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |